0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Stent System Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-25P12353
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Drug Eluting Stent System Market Research Report 2022
BUY CHAPTERS

Global Drug Eluting Stent System Market Research Report 2024

Code: QYRE-Auto-25P12353
Report
June 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Eluting Stent System Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drug Eluting Stent System Market

Drug Eluting Stent System Market

It is used to treat narrowed or blocked blood vessels in the heart by reflowing blood through the blood vessels with an inflated balloon. A coronary stent is then placed into the vessel to ensure it remains open. Two types of stents are available, one that is coated with a drug to reduce the risk of future blockages (drug-eluting stents) and one that is uncoated (bare-metal stents).
The global Drug Eluting Stent System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Stent System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Stent System.

Report Scope

The Drug Eluting Stent System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Stent System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Stent System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Eluting Stent System Market Report

Report Metric Details
Report Name Drug Eluting Stent System Market
CAGR 5%
Segment by Type
  • High Molecular Polymer Carrier
  • No High Molecular Polymer Carrier
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology, Yinyi Biotech CO.,LTD.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Eluting Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Eluting Stent System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Eluting Stent System Market report?

Ans: The main players in the Drug Eluting Stent System Market are Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology, Yinyi Biotech CO.,LTD.

What are the Application segmentation covered in the Drug Eluting Stent System Market report?

Ans: The Applications covered in the Drug Eluting Stent System Market report are Hospitals, Clinics

What are the Type segmentation covered in the Drug Eluting Stent System Market report?

Ans: The Types covered in the Drug Eluting Stent System Market report are High Molecular Polymer Carrier, No High Molecular Polymer Carrier

1 Drug Eluting Stent System Market Overview
1.1 Product Overview and Scope of Drug Eluting Stent System
1.2 Drug Eluting Stent System Segment by Type
1.2.1 Global Drug Eluting Stent System Market Value Comparison by Type (2024-2030)
1.2.2 High Molecular Polymer Carrier
1.2.3 No High Molecular Polymer Carrier
1.3 Drug Eluting Stent System Segment by Application
1.3.1 Global Drug Eluting Stent System Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Drug Eluting Stent System Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Stent System Revenue 2019-2030
1.4.2 Global Drug Eluting Stent System Sales 2019-2030
1.4.3 Global Drug Eluting Stent System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Eluting Stent System Market Competition by Manufacturers
2.1 Global Drug Eluting Stent System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Eluting Stent System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Eluting Stent System Average Price by Manufacturers (2019-2024)
2.4 Global Drug Eluting Stent System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Stent System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Stent System, Product Type & Application
2.7 Drug Eluting Stent System Market Competitive Situation and Trends
2.7.1 Drug Eluting Stent System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Stent System Players Market Share by Revenue
2.7.3 Global Drug Eluting Stent System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Stent System Retrospective Market Scenario by Region
3.1 Global Drug Eluting Stent System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Eluting Stent System Global Drug Eluting Stent System Sales by Region: 2019-2030
3.2.1 Global Drug Eluting Stent System Sales by Region: 2019-2024
3.2.2 Global Drug Eluting Stent System Sales by Region: 2025-2030
3.3 Global Drug Eluting Stent System Global Drug Eluting Stent System Revenue by Region: 2019-2030
3.3.1 Global Drug Eluting Stent System Revenue by Region: 2019-2024
3.3.2 Global Drug Eluting Stent System Revenue by Region: 2025-2030
3.4 North America Drug Eluting Stent System Market Facts & Figures by Country
3.4.1 North America Drug Eluting Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Eluting Stent System Sales by Country (2019-2030)
3.4.3 North America Drug Eluting Stent System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Stent System Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Eluting Stent System Sales by Country (2019-2030)
3.5.3 Europe Drug Eluting Stent System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Stent System Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Eluting Stent System Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Eluting Stent System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Eluting Stent System Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Eluting Stent System Sales by Country (2019-2030)
3.7.3 Latin America Drug Eluting Stent System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Stent System Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Eluting Stent System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Eluting Stent System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Stent System Sales by Type (2019-2030)
4.1.1 Global Drug Eluting Stent System Sales by Type (2019-2024)
4.1.2 Global Drug Eluting Stent System Sales by Type (2025-2030)
4.1.3 Global Drug Eluting Stent System Sales Market Share by Type (2019-2030)
4.2 Global Drug Eluting Stent System Revenue by Type (2019-2030)
4.2.1 Global Drug Eluting Stent System Revenue by Type (2019-2024)
4.2.2 Global Drug Eluting Stent System Revenue by Type (2025-2030)
4.2.3 Global Drug Eluting Stent System Revenue Market Share by Type (2019-2030)
4.3 Global Drug Eluting Stent System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Eluting Stent System Sales by Application (2019-2030)
5.1.1 Global Drug Eluting Stent System Sales by Application (2019-2024)
5.1.2 Global Drug Eluting Stent System Sales by Application (2025-2030)
5.1.3 Global Drug Eluting Stent System Sales Market Share by Application (2019-2030)
5.2 Global Drug Eluting Stent System Revenue by Application (2019-2030)
5.2.1 Global Drug Eluting Stent System Revenue by Application (2019-2024)
5.2.2 Global Drug Eluting Stent System Revenue by Application (2025-2030)
5.2.3 Global Drug Eluting Stent System Revenue Market Share by Application (2019-2030)
5.3 Global Drug Eluting Stent System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Drug Eluting Stent System Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Drug Eluting Stent System Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Biosensors
6.3.1 Biosensors Corporation Information
6.3.2 Biosensors Description and Business Overview
6.3.3 Biosensors Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biosensors Drug Eluting Stent System Product Portfolio
6.3.5 Biosensors Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Corporation Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Terumo Drug Eluting Stent System Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 MicroPort
6.5.1 MicroPort Corporation Information
6.5.2 MicroPort Description and Business Overview
6.5.3 MicroPort Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MicroPort Drug Eluting Stent System Product Portfolio
6.5.5 MicroPort Recent Developments/Updates
6.6 Lepu Medical
6.6.1 Lepu Medical Corporation Information
6.6.2 Lepu Medical Description and Business Overview
6.6.3 Lepu Medical Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lepu Medical Drug Eluting Stent System Product Portfolio
6.6.5 Lepu Medical Recent Developments/Updates
6.7 B.Braun
6.6.1 B.Braun Corporation Information
6.6.2 B.Braun Description and Business Overview
6.6.3 B.Braun Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B.Braun Drug Eluting Stent System Product Portfolio
6.7.5 B.Braun Recent Developments/Updates
6.8 Atrium Medical
6.8.1 Atrium Medical Corporation Information
6.8.2 Atrium Medical Description and Business Overview
6.8.3 Atrium Medical Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Atrium Medical Drug Eluting Stent System Product Portfolio
6.8.5 Atrium Medical Recent Developments/Updates
6.9 SINOMED
6.9.1 SINOMED Corporation Information
6.9.2 SINOMED Description and Business Overview
6.9.3 SINOMED Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SINOMED Drug Eluting Stent System Product Portfolio
6.9.5 SINOMED Recent Developments/Updates
6.10 LBC
6.10.1 LBC Corporation Information
6.10.2 LBC Description and Business Overview
6.10.3 LBC Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 LBC Drug Eluting Stent System Product Portfolio
6.10.5 LBC Recent Developments/Updates
6.11 Essen Technology
6.11.1 Essen Technology Corporation Information
6.11.2 Essen Technology Drug Eluting Stent System Description and Business Overview
6.11.3 Essen Technology Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Essen Technology Drug Eluting Stent System Product Portfolio
6.11.5 Essen Technology Recent Developments/Updates
6.12 Yinyi Biotech CO.,LTD.
6.12.1 Yinyi Biotech CO.,LTD. Corporation Information
6.12.2 Yinyi Biotech CO.,LTD. Drug Eluting Stent System Description and Business Overview
6.12.3 Yinyi Biotech CO.,LTD. Drug Eluting Stent System Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yinyi Biotech CO.,LTD. Drug Eluting Stent System Product Portfolio
6.12.5 Yinyi Biotech CO.,LTD. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Stent System Industry Chain Analysis
7.2 Drug Eluting Stent System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Stent System Production Mode & Process
7.4 Drug Eluting Stent System Sales and Marketing
7.4.1 Drug Eluting Stent System Sales Channels
7.4.2 Drug Eluting Stent System Distributors
7.5 Drug Eluting Stent System Customers
8 Drug Eluting Stent System Market Dynamics
8.1 Drug Eluting Stent System Industry Trends
8.2 Drug Eluting Stent System Market Drivers
8.3 Drug Eluting Stent System Market Challenges
8.4 Drug Eluting Stent System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Drug Eluting Stent System Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Drug Eluting Stent System Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Drug Eluting Stent System Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Drug Eluting Stent System Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Drug Eluting Stent System Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Drug Eluting Stent System Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Drug Eluting Stent System Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Drug Eluting Stent System Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Drug Eluting Stent System, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Drug Eluting Stent System, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Drug Eluting Stent System, Product Type & Application
    Table 12. Global Key Manufacturers of Drug Eluting Stent System, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Drug Eluting Stent System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Stent System as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Drug Eluting Stent System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Drug Eluting Stent System Sales by Region (2019-2024) & (K Units)
    Table 18. Global Drug Eluting Stent System Sales Market Share by Region (2019-2024)
    Table 19. Global Drug Eluting Stent System Sales by Region (2025-2030) & (K Units)
    Table 20. Global Drug Eluting Stent System Sales Market Share by Region (2025-2030)
    Table 21. Global Drug Eluting Stent System Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Drug Eluting Stent System Revenue Market Share by Region (2019-2024)
    Table 23. Global Drug Eluting Stent System Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Drug Eluting Stent System Revenue Market Share by Region (2025-2030)
    Table 25. North America Drug Eluting Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Drug Eluting Stent System Sales by Country (2019-2024) & (K Units)
    Table 27. North America Drug Eluting Stent System Sales by Country (2025-2030) & (K Units)
    Table 28. North America Drug Eluting Stent System Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Drug Eluting Stent System Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Drug Eluting Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Drug Eluting Stent System Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Drug Eluting Stent System Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Drug Eluting Stent System Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Drug Eluting Stent System Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Drug Eluting Stent System Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Drug Eluting Stent System Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Drug Eluting Stent System Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Drug Eluting Stent System Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Drug Eluting Stent System Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Drug Eluting Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Drug Eluting Stent System Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Drug Eluting Stent System Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Drug Eluting Stent System Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Drug Eluting Stent System Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Drug Eluting Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Drug Eluting Stent System Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Drug Eluting Stent System Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Drug Eluting Stent System Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Drug Eluting Stent System Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Drug Eluting Stent System Sales (K Units) by Type (2019-2024)
    Table 51. Global Drug Eluting Stent System Sales (K Units) by Type (2025-2030)
    Table 52. Global Drug Eluting Stent System Sales Market Share by Type (2019-2024)
    Table 53. Global Drug Eluting Stent System Sales Market Share by Type (2025-2030)
    Table 54. Global Drug Eluting Stent System Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Drug Eluting Stent System Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Drug Eluting Stent System Revenue Market Share by Type (2019-2024)
    Table 57. Global Drug Eluting Stent System Revenue Market Share by Type (2025-2030)
    Table 58. Global Drug Eluting Stent System Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Drug Eluting Stent System Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Drug Eluting Stent System Sales (K Units) by Application (2019-2024)
    Table 61. Global Drug Eluting Stent System Sales (K Units) by Application (2025-2030)
    Table 62. Global Drug Eluting Stent System Sales Market Share by Application (2019-2024)
    Table 63. Global Drug Eluting Stent System Sales Market Share by Application (2025-2030)
    Table 64. Global Drug Eluting Stent System Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Drug Eluting Stent System Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Drug Eluting Stent System Revenue Market Share by Application (2019-2024)
    Table 67. Global Drug Eluting Stent System Revenue Market Share by Application (2025-2030)
    Table 68. Global Drug Eluting Stent System Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Drug Eluting Stent System Price (US$/Unit) by Application (2025-2030)
    Table 70. Medtronic Corporation Information
    Table 71. Medtronic Description and Business Overview
    Table 72. Medtronic Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Medtronic Drug Eluting Stent System Product
    Table 74. Medtronic Recent Developments/Updates
    Table 75. Boston Scientific Corporation Information
    Table 76. Boston Scientific Description and Business Overview
    Table 77. Boston Scientific Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Boston Scientific Drug Eluting Stent System Product
    Table 79. Boston Scientific Recent Developments/Updates
    Table 80. Biosensors Corporation Information
    Table 81. Biosensors Description and Business Overview
    Table 82. Biosensors Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Biosensors Drug Eluting Stent System Product
    Table 84. Biosensors Recent Developments/Updates
    Table 85. Terumo Corporation Information
    Table 86. Terumo Description and Business Overview
    Table 87. Terumo Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Terumo Drug Eluting Stent System Product
    Table 89. Terumo Recent Developments/Updates
    Table 90. MicroPort Corporation Information
    Table 91. MicroPort Description and Business Overview
    Table 92. MicroPort Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. MicroPort Drug Eluting Stent System Product
    Table 94. MicroPort Recent Developments/Updates
    Table 95. Lepu Medical Corporation Information
    Table 96. Lepu Medical Description and Business Overview
    Table 97. Lepu Medical Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Lepu Medical Drug Eluting Stent System Product
    Table 99. Lepu Medical Recent Developments/Updates
    Table 100. B.Braun Corporation Information
    Table 101. B.Braun Description and Business Overview
    Table 102. B.Braun Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. B.Braun Drug Eluting Stent System Product
    Table 104. B.Braun Recent Developments/Updates
    Table 105. Atrium Medical Corporation Information
    Table 106. Atrium Medical Description and Business Overview
    Table 107. Atrium Medical Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Atrium Medical Drug Eluting Stent System Product
    Table 109. Atrium Medical Recent Developments/Updates
    Table 110. SINOMED Corporation Information
    Table 111. SINOMED Description and Business Overview
    Table 112. SINOMED Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. SINOMED Drug Eluting Stent System Product
    Table 114. SINOMED Recent Developments/Updates
    Table 115. LBC Corporation Information
    Table 116. LBC Description and Business Overview
    Table 117. LBC Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. LBC Drug Eluting Stent System Product
    Table 119. LBC Recent Developments/Updates
    Table 120. Essen Technology Corporation Information
    Table 121. Essen Technology Description and Business Overview
    Table 122. Essen Technology Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Essen Technology Drug Eluting Stent System Product
    Table 124. Essen Technology Recent Developments/Updates
    Table 125. Yinyi Biotech CO.,LTD. Corporation Information
    Table 126. Yinyi Biotech CO.,LTD. Description and Business Overview
    Table 127. Yinyi Biotech CO.,LTD. Drug Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Yinyi Biotech CO.,LTD. Drug Eluting Stent System Product
    Table 129. Yinyi Biotech CO.,LTD. Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Drug Eluting Stent System Distributors List
    Table 133. Drug Eluting Stent System Customers List
    Table 134. Drug Eluting Stent System Market Trends
    Table 135. Drug Eluting Stent System Market Drivers
    Table 136. Drug Eluting Stent System Market Challenges
    Table 137. Drug Eluting Stent System Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Drug Eluting Stent System
    Figure 2. Global Drug Eluting Stent System Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Drug Eluting Stent System Market Share by Type in 2023 & 2030
    Figure 4. High Molecular Polymer Carrier Product Picture
    Figure 5. No High Molecular Polymer Carrier Product Picture
    Figure 6. Global Drug Eluting Stent System Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Drug Eluting Stent System Market Share by Application in 2023 & 2030
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Global Drug Eluting Stent System Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Drug Eluting Stent System Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Drug Eluting Stent System Sales (2019-2030) & (K Units)
    Figure 13. Global Drug Eluting Stent System Average Price (US$/Unit) & (2019-2030)
    Figure 14. Drug Eluting Stent System Report Years Considered
    Figure 15. Drug Eluting Stent System Sales Share by Manufacturers in 2023
    Figure 16. Global Drug Eluting Stent System Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Drug Eluting Stent System Players: Market Share by Revenue in 2023
    Figure 18. Drug Eluting Stent System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Drug Eluting Stent System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Drug Eluting Stent System Sales Market Share by Country (2019-2030)
    Figure 21. North America Drug Eluting Stent System Revenue Market Share by Country (2019-2030)
    Figure 22. United States Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Drug Eluting Stent System Sales Market Share by Country (2019-2030)
    Figure 25. Europe Drug Eluting Stent System Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Drug Eluting Stent System Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Drug Eluting Stent System Revenue Market Share by Region (2019-2030)
    Figure 33. China Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Latin America Drug Eluting Stent System Sales Market Share by Country (2019-2030)
    Figure 41. Latin America Drug Eluting Stent System Revenue Market Share by Country (2019-2030)
    Figure 42. Mexico Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Brazil Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Argentina Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Drug Eluting Stent System Sales Market Share by Country (2019-2030)
    Figure 46. Middle East & Africa Drug Eluting Stent System Revenue Market Share by Country (2019-2030)
    Figure 47. Turkey Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. UAE Drug Eluting Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Global Sales Market Share of Drug Eluting Stent System by Type (2019-2030)
    Figure 51. Global Revenue Market Share of Drug Eluting Stent System by Type (2019-2030)
    Figure 52. Global Drug Eluting Stent System Price (US$/Unit) by Type (2019-2030)
    Figure 53. Global Sales Market Share of Drug Eluting Stent System by Application (2019-2030)
    Figure 54. Global Revenue Market Share of Drug Eluting Stent System by Application (2019-2030)
    Figure 55. Global Drug Eluting Stent System Price (US$/Unit) by Application (2019-2030)
    Figure 56. Drug Eluting Stent System Value Chain
    Figure 57. Drug Eluting Stent System Production Process
    Figure 58. Channels of Distribution (Direct Vs Distribution)
    Figure 59. Distributors Profiles
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart